Transcripts
Ascendis Pharma A/S (ASND) earnings call transcripts
Earnings call transcripts for Ascendis Pharma A/S, with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed accelerating launches and TransCon platform productivity as supporting long-term growth, while declining to quantify early TransCon CNP trends.
Aug 13, 2026Confident0.82